MedPath

Operating Room Air Filtration/Sterilization

Not Applicable
Active, not recruiting
Conditions
Surgery
Interventions
Device: Functioning Aerus air filtration/sterilization
Device: Deactivated Aerus air filtration/sterilization
Registration Number
NCT04610294
Lead Sponsor
The Cleveland Clinic
Brief Summary

Determine whether operating room air filtration and sterilization with the ActivePure system reduces a composite of serious surgical site infections, infection-related complications, and death within 30 days after surgery.

Detailed Description

The investigators primary goal is thus to determine whether supplemental filtering and sterilizing operating room air reduces a composite of serious surgical site infections, infection-related complications, and death within 30 days after surgery. The primary outcome will be restricted to inpatients. However, outpatients will be simultaneously enrolled given the trial's cluster design. Sample-size is based on our primary inpatient analysis, N= 66,273 inpatients. Available outpatients will be included for analysis of our secondary outcome which includes both inpatients and outpatients.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
66273
Inclusion Criteria
  • All patients in designated adult operating rooms
  • American Society of Anesthesiologists physical status 1-4.
  • Surgery lasting at least 1 hour.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Aerus air sterilizationFunctioning Aerus air filtration/sterilizationAerus air sterilization system will be used in an operating room, in addition to routine room air filtration
Conventional air handlingDeactivated Aerus air filtration/sterilizationOnly routine room air filtration will be used in an operation room.
Primary Outcome Measures
NameTimeMethod
Serious surgical site infections and related complication in previously uninfected surgical inpatients30 days after surgery

Composite of serious surgical site infections, infection-related complications, and death in surgical inpatients without present-on-admission composite infection components

Secondary Outcome Measures
NameTimeMethod
Serious surgical site infections and related complication in previously uninfected surgical inpatients and outpatients30 days after surgery

Composite of serious surgical site infections, infection-related complications, and death in surgical inpatients and outpatients without present-on-admission composite infection components

Trial Locations

Locations (1)

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath